Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec 2.
doi: 10.1007/s11030-024-11046-w. Online ahead of print.

Influence of hydrophobicity on the antimicrobial activity of helical antimicrobial peptides: a study focusing on three mastoparans

Affiliations

Influence of hydrophobicity on the antimicrobial activity of helical antimicrobial peptides: a study focusing on three mastoparans

Binh Le Huy et al. Mol Divers. .

Abstract

Hydrophobicity is crucial for the interaction between amphipathic antimicrobial peptides and microbial pathogens. However, it is difficult to fully understand the impact of this factor because the biological functions are also influenced by other structural properties, including peptide length, net charge, hydrophilicity, secondary structure, and hydrophobic moment. This study compares three natural antimicrobial peptides-mastoparan C, mastoparan-AF, and mastoparan L-where hydrophobicity varies but other structural features remain nearly identical. Mastoparan C, the most hydrophobic peptide, displays the highest helical content and hemolytic activity, whereas mastoparan-AF, with slightly lower hydrophobicity, demonstrates superior selectivity. In contrast, mastoparan L, the least hydrophobic peptide, exhibits the weakest antimicrobial potency and lowest hemolytic activity, despite showing the least self-assembly. Overall, this study suggests that optimal hydrophobicity, rather than the highest value, enhances antimicrobial efficacy while minimizing hemolytic activity.

Keywords: Antimicrobial peptides; Hydrophobicity; Mastoparans; Structure–activity relationships.

PubMed Disclaimer

Conflict of interest statement

Declarations. Conflict of interest: We have no conflict of interest to declare. Informed consent: Not relevant.

Similar articles

Cited by

References

    1. Lazzaro BP, Zasloff M, Rolff J (2020) Antimicrobial peptides: application informed by evolution. Science 368:eaau5480. https://doi.org/10.1126/science.aau5480 - DOI - PubMed - PMC
    1. Shi G, Kang X, Dong F et al (2022) DRAMP 3.0: an enhanced comprehensive data repository of antimicrobial peptides. Nucleic Acids Res 50:D488–D496. https://doi.org/10.1093/nar/gkab651 - DOI - PubMed
    1. Li W, Separovic F, O’Brien-Simpson NM, Wade JD (2021) Chemically modified and conjugated antimicrobial peptides against superbugs. Chem Soc Rev 50:4932–4973. https://doi.org/10.1039/D0CS01026J - DOI - PubMed
    1. Luong HX, Thanh TT, Tran TH (2020) Antimicrobial peptides—advances in development of therapeutic applications. Life Sci 260:118407. https://doi.org/10.1016/j.lfs.2020.118407 - DOI - PubMed - PMC
    1. Mahlapuu M, Björn C, Ekblom J (2020) Antimicrobial peptides as therapeutic agents: opportunities and challenges. Crit Rev Biotechnol 40:978–992. https://doi.org/10.1080/07388551.2020.1796576 - DOI - PubMed

LinkOut - more resources